Breaking
Friday, June 19, 2026
🇺🇸 Americas · Directory profile

Optibrium - Transforming Drug Discovery

Visit website

Company overview

Optibrium provides AI-powered software platforms for small molecule design, optimization, and data analysis in drug discovery. Their solutions, including StarDrop, Cerella, and Inspyra, support hit-to-lead and lead optimization by integrating generative chemistry, 3D modeling, and predictive ADME models to enhance efficiency and reduce synthesis needs by up to 90%. These tools enable pharmaceutical teams to make data-driven decisions, accelerating progression from hit to candidate.

Optibrium - Transforming Drug Discovery is listed in the NovaPharmaNews Supplier Hub as a Software & Digital Lab partner serving United States & Americas. Core focus areas include optibrium, drug discovery software, ai chemistry, stardrop, small molecule design.

Industry categories: Software & Digital Lab. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.

Products and technologies associated with Optibrium - Transforming Drug Discovery include Software — relevant for pharmaceutical discovery, process development, and GMP manufacturing workflows.

Structured facts

Website
https://optibrium.com/
Categories
Software & Digital Lab
Markets served
United States & Americas
Keywords
optibrium, drug discovery software, ai chemistry, stardrop, small molecule design

Products & technologies

  • Software

Therapeutic areas

  • Small Molecule

Markets served

  • United States & Americas

Industry categories

Company timeline

  1. — Profile published on NovaPharmaNews
  2. — Profile last updated

Related suppliers in category

Frequently asked questions

What core capabilities does Optibrium offer for drug discovery?
Optibrium offers StarDrop for molecular design and data visualization, Cerella for AI-guided optimization, and Inspyra for generative chemistry and 3D design, supporting data analysis, SAR, compound generation, and prioritization.
How does Optibrium's software improve R&D efficiency?
Their AI platforms speed up early-stage research, cut synthesis requirements by up to 90%, lower R&D costs, and generate optimized compounds faster than competitors.
Who are Optibrium's typical customers and geographies?
Optibrium serves leading global pharma, biotech, agrochemical, and academic groups worldwide, with a focus on collaborative platforms for international teams.